Australia's New Product Info Format For Drugs Kicks In
Drug sponsors in Australia should be preparing their product information (PI) documents in accordance with a new format that came into effect in on Jan. 1. The revised format makes critical clinical information more accessible and aligns the Australian PI format with that of other international regulators.
You may also be interested in...
The TGA says that its new search function to help generic drug sponsors identify new and updated product information will become more valuable over time.
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. While the European Medicines Agency has launched an investigation, Australia is examining the need for specific warnings about risks of vaccination in the very frail elderly or terminally ill patients.
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.